Korean biotech sets up shop in Cambridge with help of MIT’s Bob Langer


A six-year-old South Korean biotech startup is carving out plans for the U.S. by establishing a subsidiary based in Cambridge.

Previous New documents outline cost, details of Amazon distribution center in Niagara
Next Hostess puts its packaging on a diet as part of ESG push